EN
简体
繁体
EN
简体
繁体
About Us
Company Overview
Milestones
Our Team
Investors
Partnership & Recognition
Contact Us
Pipeline & Products
Pipeline
Rare Oncology
Rare Diseases
Gene Therapy
Other Onc.
Approved Products
Hunterase®
Nerlynx®
Caphosol®
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Corporate Governance
Stock Information
Presentations & Webcasts
Financial Calendar
Email Alert and IR Contact
Media & News
Media Reports
Press Release
Corporate Culture & Career
Corporate Culture
Open Positions
Financial Reports
2021
2021 Annual Report
Annual Results Announcement for The Year Ended December 31, 2021
